PPARGC1A and Insulin resistance: Proteins involved in enhancing mitochondrial function and limiting ROS accumulation, such as PGC-1α, Sirt1, and Sirt3, are of interest as specific therapeutic targets to improve insulin resistance observed in NAFLD progression.